Corneal graft rejection: Donor and receiver implication;Le rejet de greffe de cornée: Implication du donneur et du receveur

Journal Francais d'Ophtalmologie

Volumn 28, Issue 6, 2005, Pages 631-634

  Trigui, A ^a,b   Smaoui, M ^a   Masmoudi, J ^a   Mhiri, W ^a   Maatoug, S ^a   Feki, J ^a  

^a HEDI CHAKER HOSPITAL   (Tunisia)

^b HABIB BOURGUIBA HOSPITAL   (Tunisia)

Author keywords

Cornea; Donor; Graft rejection; Recipient

Indexed keywords

ANTIVIRUS AGENT; CORTICOSTEROID;

ADULT; AGE DISTRIBUTION; CAUSE OF DEATH; CHI SQUARE DISTRIBUTION; CONTROLLED STUDY; CORNEA TRANSPLANTATION; CORTICOSTEROID THERAPY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; KERATOPLASTY; MAJOR CLINICAL STUDY; MALE; NEOVASCULARIZATION (PATHOLOGY); ORGAN DONOR; ORGAN PRESERVATION; RECIPIENT; RETROSPECTIVE STUDY; REVIEW; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; SUTURE; TREATMENT INDICATION;

EID: 22044443888     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0181-5512(05)81108-8     Document Type: Review

References (20)

1. Scheer S, Touzeau O, Vorderie V, Laroche L. L'immunosupression dans la greffe de cornée. J Fr Ophtalmol, 2003;26:637-47.
2. Borderie V, Delbosc B, Kantelip B, Laroche L. Le rejet d'allogreffe de cornée. J Fr Ophtalmol, 1998;21,8:596-610.
3. Paufique L, Sourdille GP, Offret G. Les greffes de la cornée. Paris, Masson, 1948.
4. Borderie VM, Laroche L. Measurmement of irregular astigmatism using semimendian data from videokeratographs. J. Refract Surg, 1996;12:595-600.
5. Alphen KV, Volker Dieben HG, D'Amaro J. When is a tissue-typed cornea necessary? Documenta Ophthalmologica, 1987;67:73-81.
6. Volker Dieben HG. The effect of immunological and non-immunological factor on corneal graft survival. Thesis. Dordrecht:Junk, 1984.
7. Zannen A. Immunology in corneal grafting, experimental studies. Bull Soc Belge Ophthalmol, 1992,246:47-58.
8. Miroux LB. Bilan de deux années de kératoplasties au centre hospitalier de Brest: à propos de 102 cas, 1984-1985. Thèse en médecine n° 3052, 1988, Brest, France.
9. Wiggins RE, Cobo M, Foulks GN. Results of penetrating keratoplasty by residents. Arch Ophthalmol, 1998;108:851-3.
10. Chan CML, Wong TY, Yeong SM, Lim TH, Tan DTH. Penetrating keratoplasty in the Singapore National Eye Center and donor cornea acquisition in the Singapore National Eye Bank. Annals Academy of Medecine, 1997;26:395-400.
11. Chaker M, Chaabouni F. Kératoplastie transfixiante de 1994 à 1998: indications, prise en charge. Thèse en médecine, 2000, Tunis, Tunisie.
12. Faure JP, Bloch Michel E, Le Hoang P, Vadot E. Immunologie de l'œil; Masson, 1988: p. 375-84.
13. Weekers JF. Endothélium cornéen et kératoplasties. J Fr Ophtalmol, 1987;10:331-45.
14. Armitage WJ, Easty DL. Factors influancing the suitability of organ-cultured corneas for transplantation. Invest Ophthalmol Vis Sci, 1997;38:16-24.
15. Wilhelmus KR, Stulting RD, Sugar J, Khan MM. Primary corneal graft failuree. A/national reporting system. Arch Ophthalmol, 1995;113:1497-502.
16. Boisjoly HM, Roy R, Bernard PM, Dube I, Laug Hrea PA, Bazin R. Association between corneal allograft reactions and HLA compatibility. Ophthalmolgy, 1990;97:1689-98.
17. Hill JC. The mechanism and management of corneal graft rejection. Kluger Publications, Amsterdam, 1996.
18. Zimon AL, Langston DP. Long-term oral acyclovir therapy. Effect on recurrent infectious herpes simplex keratitis in patients with and without grafts. Ophthalmology, 1996;103:1399-404.
19. Insler MS, Bryan P. Visual results in repeat penetrating keraplasty. Am J Ophthalmol, 1986;102:371-71.
20. Alldrege OC, Krachmer JH. Clinical types of corneal transplant rejection. Arch Ophthalmol, 1981;99:599-604.